Loading viewer...
conference
Format: PDF conference
Presentation delivered at the 41st Annual J.P. Morgan Healthcare Conference in January 2023. The company is advancing development programs across multiple therapeutic areas including Alzheimer's, Parkinson's, Migraine, and Hypercholesterolemia, with discussions of discovery, research activities, and anticipated clinical development timelines for product candidates.
investor_presentation
18 Pages
conference
20 Pages
The Habit Restaurants
Hanmi Financial Corporation 2022 Community Bank Investor Conference
conferenceconference
36 Pages
Hanmi Financial Corporation
TETRA Technologies 2023 Scotia Howard Weil Energy Conference
conferenceconference
33 Pages
TETRA Technologies, Inc.
Ryerson Holding 2023 KeyBanc Industrials Conference Presentation
conferenceconference
62 Pages
Ryerson Holding Corporation